Kongenitale Stationäre Nachtblindheit (CSNB) MDR1 Acatalasemia is a genetic disease

Acatalasemia is a genetic disease that affects humans and animals

which contain a specific protein called glial fibrillary acidic protein (GFAP)

there is a protentional higher risk of developing DCM if a dog is carrier or affected by two or more combinations of risk variants

immune deficiency

important for cell metabolism in higher organisms

Kongenitale Stationäre Nachtblindheit (CSNB) MDR1 Acatalasemia is a genetic diseaseCongenital Stationary Night Blindness is an eye disease with slow retinal degeneration that at first stage causes night blindness. Day vision in affected dogs ranges from normal vision to profound day blindness. The disease has a characteristic clinical phenotype, consisting of profound visual impairment present already at 5 6 weeks of age. Older dogs may show subtle retinal abnormalities indicative of a slowly progressive retinal degenerative